By a News Reporter-Staff News Editor at Pharma Business Week — According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for “ALPROLIX” by Brenda Campbell, Trademark Paralegal, representing Biogen Idec MA. This application was made available to the public on June 27, 2014 (see also Pharmaceutical Companies).
The international trademark goods and services class code for this trademark application is 044.
The serial number for this application is 86310233.
As submitted by the applicant, this trademark application relates to the following goods and services: Providing medical information in the field of hemophilia.
The owner/registrar information for this application is: Brenda Campbell, Trademark Paralegal, Biogen Idec MA, 225 Binney St, Cambridge, MA 02142-1031.
Keywords for this news article include: Pharmaceutical Companies, Trademarks, Biogen Idec MA, Biotechnology Companies.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC
Trademark Application for “ALPROLIX” Filed by Biogen Idec MA
By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for
- 1 min Read
- 07.9.2014
A weekly five-point roundup of critical events in fintech, the future of finance and the next wave of banking industry transformation.
Of course, I couldn’t envision the extent to which AI would take off when I initially urged you to buy Nvidia.
Vulnerability depends on factors such as energy self-sufficiency, alternative energy adoption and economic resilience.
They're now able to use AI to assess data generated by everything from drills and trucks to conveyors and ships.
Trucking is one of the purest forms of economic supply and demand out there.
A weekly five-point roundup of critical events in the energy transition and the implications of climate change for business and finance.
